TREE NEWS update: Two papers in the journal Circulation on Nov. 17 (Beijing time) presented a minimally invasive transapical beating-heart septal myectomy (TA-BSM) developed by Prof. Wei Xiang’s cardiac surgery team at Tongji Hospital, Huazhong University of Science and Technology, for hypertrophic cardiomyopathy. The procedure covers both obstructive and non-obstructive forms of the disease, the team said, breaking through limits of conventional treatment and offering a Chinese approach for global care.
Chinese Team’s Beating-Heart Septal Procedure Published in Circulation
Publication in Circulation gives a Chinese surgical team's TA-BSM approach international peer review, which matters for a procedure pitched as covering both obstructive and non-obstructive hypertrophic cardiomyopathy rather than a single phenotype. The claim of breaking through conventional treatment limits is the team's own framing, and the two-paper presentation is the kind of evidence base clinicians outside China will scrutinize before treating this as a generalizable option. Whether the technique's applicability holds beyond the originating center is the open question.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.